Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Elite Prescription drugs, Inc. (ELTP) Q2 2025 Earnings Convention Name Transcript

0


Elite Prescription drugs, Inc. (OTCQB:ELTP) Q2 2025 Earnings Convention Name November 15, 2024 11:30 AM ET

Firm Contributors

Nasrat Hakim – President and CEO
Carter Ward – CFO

Convention Name Contributors

Operator

Good morning, girls and gents, and welcome to the Elite Prescription drugs Second Quarter of Fiscal Yr 2025 Convention Name.

Right now all traces have been positioned on a listen-only mode. Earlier than administration begins talking, the convention has the next assertion. Elite wish to remind listeners that remarks made throughout this name might comprise forward-looking statements that contain dangers and uncertainties which can be topic to alter at any time, together with however not restricted to, statements about Elite’s expectations relating to ahead working outcomes.

Ahead-looking statements are made pursuant to the Secure Harbor provisions of the Federal Securities Legal guidelines and signify administration’s present expectations. Precise outcomes might differ materially. Elite disclaims any obligation to replace or revise its forward-looking statements, besides as required by legislation. Extra full data relating to forward-looking statements, dangers and uncertainties will be discovered within the report Elite recordsdata with the SEC which is on the market on Elite’s web site at elitepharma.com beneath the Investor Relations part. Elite encourages you to evaluate these paperwork fastidiously.

With that lined, it’s now my pleasure to show the ground over to your host, Mr. Nasrat Hakim, President and Chief Government Officer of Elite Prescription drugs. Sir, the ground is yours.

Nasrat Hakim

Thanks, Matthew and good morning, girls and gents, and thanks for becoming a member of us at this time. My identify is Nasrat Hakim. I’m Elite’s Chairman and CEO. That is our earnings name. Our CFO, Carter Ward provides you with a abstract of the corporate’s financials, after which I will provide you with an replace and reply among the questions you’ve got submitted to Dianne.

Mr. Ward, the ground is yours.

Carter Ward

Leave a Reply

Your email address will not be published. Required fields are marked *